Nasal Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction: A Potential Use in Guiding Antibiotic Therapy for Pneumonia | Zendy

Jennifer Johnson | Zendy; Michael Wright | Zendy; Lyndsay Sheperd | Zendy; Daniel M. Musher | Zendy; Bich N. Dang | Zendy

Open Access

Nasal Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction: A Potential Use in Guiding Antibiotic Therapy for Pneumonia

Author(s) -

Jennifer Johnson,

Michael Wright,

Lyndsay Sheperd,

Daniel M. Musher,

Bich N. Dang

Publication year - 2014

Publication title -

the permanente journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.445

H-Index - 30

eISSN - 1552-5775

pISSN - 1552-5767

DOI - 10.7812/tpp/14-101

Subject(s) - medicine , staphylococcus aureus , discontinuation , pneumonia , antibiotics , methicillin resistant staphylococcus aureus , respiratory tract , respiratory tract infections , ventilator associated pneumonia , lower respiratory tract infection , retrospective cohort study , polymerase chain reaction , microbiology and biotechnology , respiratory system , bacteria , genetics , biology , biochemistry , chemistry , gene

The role at admission of nasal polymerase chain reaction (PCR) for patients with methicillin-resistant Staphylococcus aureus (MRSA) in guiding antibiotic therapy for lower respiratory tract infection is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research